Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Lilly

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lilly's 2013 sales performance.

Lilly

Merck to acquire Pandion Therapeutics for $1.85bn

Merck to acquire Pandion Therapeutics for $1.85bn

A number of other pharma companies are also developing IL-2 therapies, including Eli Lilly with a  Nektar Therapeutics-partnered candidate that is currently in phase 2 trials for the treatment

Lilly signs $960m deal with Rigel to develop RIPK1 inhibitors

Lilly signs $960m deal with Rigel to develop RIPK1 inhibitors Lilly will co-develop and commercialise R552 across all indications, including autoimmune and inflammatory diseases. ... In addition, Lilly will also lead all clinical development of brain-penetrating RIPK1 inhibitors in central nervous system (CNS)

Eli Lilly promotes Anat Ashkenazi to chief financial officer

Eli Lilly promotes Anat Ashkenazi to chief financial officer Most recently, Ashkenazi served as senior vice president, controller and CFO of Lilly Research Laboratories. ... Prior to this, she served as CFO for across a number of Lilly’s global business areas.

FDA grants emergency use for Lilly’s COVID-19 antibody drug combination

FDA grants emergency use for Lilly’s COVID-19 antibody drug combination Eli Lilly’s monoclonal antibody combination treatment, bamlanivimab plus etesevimab, has gained an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for COVID-19. ... with a similar demonstrated clinical benefit,” said

EMA launches rolling review of Regeneron’s COVID-19 antibody cocktail

EMA launches rolling review of Regeneron’s COVID-19 antibody cocktail Another antibody combination treatment, developed by Eli Lilly, also recently produced promising results in high-risk COVID-19 patients. ... Across the entire study population, which included 1, 035 patients, there were 11 events in patients receiving

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics